Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IDXG

Interpace Biosciences (IDXG) Stock Price, News & Analysis

Interpace Biosciences logo

About Interpace Biosciences Stock (NASDAQ:IDXG)

Advanced Chart

Key Stats

Today's Range
$0.86
$0.91
50-Day Range
$4.75
$10.40
52-Week Range
$2.57
$10.42
Volume
24,080 shs
Average Volume
6,816 shs
Market Capitalization
$3.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IDXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Interpace Biosciences and its competitors with MarketBeat's FREE daily newsletter.

IDXG Stock News Headlines

PDI CEF: Best Time To Sell In 5 Years
PDI Declares Monthly Dividend with Over 13% Yield
Elon Musk’s New Technology
Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.tc pixel
PDI: Credit Offers Opportunity In An Expensive Market
PDI: Get In Before The Fed Changes The Tune
PDI: Inflection Point Ahead
PDI: Nothing Special... Yet
See More Headlines

IDXG Stock Analysis - Frequently Asked Questions

Interpace Biosciences, Inc. (NASDAQ:IDXG) posted its quarterly earnings data on Monday, November, 4th. The business services provider reported $0.31 EPS for the quarter. The business services provider earned $12.30 million during the quarter. Interpace Biosciences had a negative trailing twelve-month return on equity of 8.09% and a net margin of 10.39%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Interpace Biosciences investors own include Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Dynavax Technologies (DVAX), Bristol Myers Squibb (BMY), Novavax (NVAX) and Histogenics (HSGX).

Company Calendar

Last Earnings
11/04/2024
Today
8/22/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:IDXG
CIK
1054102
Employees
152
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$800 thousand
Net Margins
10.39%
Pretax Margin
10.93%
Return on Equity
-8.09%
Return on Assets
37.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.59
Quick Ratio
0.59

Sales & Book Value

Annual Sales
$40.21 million
Price / Sales
0.10
Cash Flow
$0.44 per share
Price / Cash Flow
1.99
Book Value
($14.16) per share
Price / Book
-0.06

Miscellaneous

Outstanding Shares
4,410,000
Free Float
4,167,000
Market Cap
$3.88 million
Optionable
Not Optionable
Beta
0.76
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:IDXG) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners